Advanced search×

Genome-wide association study identifies a common variant associated with risk of endometrial cancer.

Nat Genet 43(5):451-4 (2011) PMID 21499250

Endometrial cancer is the most common malignancy of the female genital tract in developed countries. To identify genetic variants associated with endometrial cancer risk, we performed a genome-wide association study involving 1,265 individuals with endometrial cancer (cases) from Australia and the UK and 5,190 controls from the Wellcome Trust Case Control Consortium. We compared genotype frequencies in cases and controls for 519,655 SNPs. Forty seven SNPs that showed evidence of association with endometrial cancer in stage 1 were genotyped in 3,957 additional cases and 6,886 controls. We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes.

DOI: 10.1038/ng.812
Version: za2963e q8za0 q8zbe q8zcf q8zd8 q8ze4 q8zf0 q8zg0

Similar articles you may find interesting…

  1. Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

    J Natl Cancer Inst 103(7):538-52 (2011) PMID 21447808 PMCID PMC3071355

    We used microarrays to compare gene expression in four primary tumors from tamoxifen-treated patients whose breast cancers did not recur vs five metastatic tumors from patients whose cancers progressed during adjuvant tamoxifen treatment. Because Rho guanine dissociation inhibitor (GDI) α was under...
  2. Targeting apoptosis pathways in lung cancer

    Cancer Lett (2010) PMID 20974517

    We describe different ways that are currently explored to induce apoptosis in lung cancer cells, specifically pathways controlled by TNF-related apoptosis-inducing ligand (TRAIL), BCL-2 family members and apoptosis inhibitory proteins (IAPs). Preclinical studies are discussed and for some agents res...
  3. A recent illustration of some essentials of circadian chronotherapy study design.

    J Clin Oncol 22(14):2971-2; author reply 2972 (2004) PMID 15254067